Script

BREAST CANCER SCREENING RATES RECOVER POST-PANDEMIC
Lucy Wallace, MD, Baylor Scott & White Health

{**ON CAM**}
BREAST CANCER SCREENINGS DROPPED SIGNIFICANTLY DURING THE COVID-19 PANDEMIC … PROMPTING CONCERN AMONG HEALTH OFFICIALS THAT WOMEN WOULD CONTINUE TO SKIP THE ANNUAL SCREENING.

{**TAKE VO**}
BUT NEW DATA SUGGESTS THOSE FEARS HAVEN’T COME TRUE. WOMEN ARE RETURNING TO ANNUAL MAMMOGRAMS.
BUT WILL THE SKIPPED SCREENINGS RESULT IN MISSED OPPORTUNITIES FOR EARLY DIAGNOSIS?
BREAST SURGEON LUCY WALLACE SAYS THAT’S A COMMON OUTCOME IN HER PRACTICE.

{**TAKE SOT**}
Lucy Wallace, MD
Baylor Scott & White Health
TRT: 17
“I can't tell you how many times I've had a patient who came in, who skipped a year or even two years because of the pandemic, and now they have a locally advanced breast cancer.”

{**ON CAM**}
DR WALLACE SAYS WHILE EARLY DETECTION THROUGH MAMMOGRAPHY IS THE GOAL .... MOST BREAST CANCERS ARE HIGHLY TREATABLE.
ACCORDING TO THE ‘SUSAN G. KOMEN’ FOUNDATION NINETY PERCENT OF WOMEN DIAGNOSED WILL BEAT THE DISEASE.